ATE254905T1 - Verwendung mindestens eines hydroxystilben in einer straffenden zusammensetzung - Google Patents

Verwendung mindestens eines hydroxystilben in einer straffenden zusammensetzung

Info

Publication number
ATE254905T1
ATE254905T1 AT99400862T AT99400862T ATE254905T1 AT E254905 T1 ATE254905 T1 AT E254905T1 AT 99400862 T AT99400862 T AT 99400862T AT 99400862 T AT99400862 T AT 99400862T AT E254905 T1 ATE254905 T1 AT E254905T1
Authority
AT
Austria
Prior art keywords
skin
treating
menopausal
fibroblast
hydroxystilben
Prior art date
Application number
AT99400862T
Other languages
English (en)
Inventor
Lionel Breton
Christel Liviero
Dominique Fagot
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE254905T1 publication Critical patent/ATE254905T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14Preparations for removing make-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99400862T 1998-04-10 1999-04-08 Verwendung mindestens eines hydroxystilben in einer straffenden zusammensetzung ATE254905T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804571A FR2777186B1 (fr) 1998-04-10 1998-04-10 Utilisation d'au moins un hydroxystilbene dans une composition raffermissante

Publications (1)

Publication Number Publication Date
ATE254905T1 true ATE254905T1 (de) 2003-12-15

Family

ID=9525161

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99400862T ATE254905T1 (de) 1998-04-10 1999-04-08 Verwendung mindestens eines hydroxystilben in einer straffenden zusammensetzung

Country Status (8)

Country Link
US (1) US6147121A (de)
EP (1) EP0953346B1 (de)
JP (1) JPH11322577A (de)
AT (1) ATE254905T1 (de)
CA (1) CA2266796A1 (de)
DE (1) DE69913023T2 (de)
ES (1) ES2212487T3 (de)
FR (1) FR2777186B1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69601765T2 (de) * 1995-09-07 1999-07-08 Oreal Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
EP1032403B1 (de) * 1997-10-24 2012-05-02 John P. Blass Nahrungsergänzungsmittel für metabolische hirnleistungsstörungen
FR2793681B1 (fr) * 1999-05-18 2001-06-22 Oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
FR2795643B1 (fr) 1999-07-02 2004-06-11 Oreal Composition cosmetique raffermissante comprenant au moins un hydroxystilbene en association avec de l'acide ascorbique
FR2796278B1 (fr) * 1999-07-16 2002-05-03 Oreal Utilisation d'au moins un hydroxystilbene comme agent anti-glycation
WO2001021165A1 (en) * 1999-09-21 2001-03-29 Rutgers, The State University Resveratrol analogs for prevention of disease
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
AU2094901A (en) * 1999-12-16 2001-06-25 Johnson & Johnson Consumer Companies, Inc. Compositions containing a retinoid and a stilbene for skin care
FR2802420B1 (fr) * 1999-12-21 2002-02-22 Oreal Utilisation du 3,3', 5,5'-tetrahydroxystilbene comme agent anti-glycation
JP4074043B2 (ja) * 2000-03-27 2008-04-09 株式会社資生堂 皮膚基底膜形成促進剤、人工皮膚形成促進剤及び人工皮膚の製造方法
JP2002293736A (ja) * 2001-03-30 2002-10-09 Sunstar Inc メーラード反応阻害剤およびそれを含有する組成物
JP4425628B2 (ja) * 2001-07-23 2010-03-03 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 細胞保護化合物、薬学的処方物および美容用処方物、ならびに方法
EP1284133B1 (de) * 2001-08-18 2006-10-11 Cognis IP Management GmbH Wirkstoffmischungen
US20030118617A1 (en) * 2001-12-21 2003-06-26 Avon Products, Inc. Resveratrol analogues
US20040029774A1 (en) * 2002-08-06 2004-02-12 Aly Gamay Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
JP3926711B2 (ja) * 2002-08-30 2007-06-06 株式会社ファンケル 表皮の偏平化を予防、防止、改善する皮膚老化防止用組成物
FR2844715B1 (fr) * 2002-09-20 2007-04-27 Af Consulting Composition pour des soins de la peau, et contenant un ou des oligomeres de resveratrol, en particulier de l'epsilone-viniferine, et ou certains de leurs derives
JP2007530417A (ja) * 2003-07-01 2007-11-01 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 細胞及び生物の寿命及びストレス応答を操作するための組成物
FR2862533B1 (fr) * 2003-11-21 2006-04-28 Oreal Utilisation cosmetique d'au moins un activateur de la production d'une interleukine 11, comme agent amincissant topique
US20050171027A1 (en) * 2003-12-29 2005-08-04 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
EP1799228B1 (de) 2004-09-14 2010-04-14 Ajinomoto Omnichem S.A. Topische zusammensetzungen mit phosphorylierten polyphenolen
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
JP2008088123A (ja) * 2006-10-03 2008-04-17 Oriza Yuka Kk 美肌用組成物
US8080583B2 (en) 2007-07-31 2011-12-20 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
US20090035240A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
US8344024B2 (en) * 2007-07-31 2013-01-01 Elc Management Llc Anhydrous cosmetic compositions containing resveratrol derivatives
US20090035236A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
US9295621B2 (en) * 2007-07-31 2016-03-29 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant
CN102617348B (zh) * 2007-09-08 2016-05-18 Elc管理有限责任公司 阿魏酸白藜芦醇酯化合物、包含该化合物的组合物及其使用方法
WO2010086736A2 (en) 2009-01-30 2010-08-05 Vitrupharma S.R.L. Novel use of the combination of resveratrol with cysteine and derivatives thereof
JP2011046660A (ja) * 2009-08-28 2011-03-10 Fujifilm Corp マトリックスメタロプロテアーゼ−2(mmp−2)阻害剤
US8686013B2 (en) * 2011-08-25 2014-04-01 Avon Products, Inc. Cosmetic use of substituted amino heterocylic carbamoyl analogs and related compounds
AU2012315683A1 (en) * 2011-09-30 2014-05-08 Elc Management Llc Personal compositions with silicone emulsifier-free natural emulsifier system
KR20140069276A (ko) * 2011-09-30 2014-06-09 이엘씨 매니지먼트 엘엘씨 실리콘 유화제-비함유 천연 유화제계를 갖는 개인 조성물
JP2013151457A (ja) * 2012-01-25 2013-08-08 Morinaga & Co Ltd マトリックスメタロプロテアーゼ−1阻害剤
JP6382197B2 (ja) 2012-08-20 2018-08-29 ロレアルL′Oreal 皮膚の老化の徴候に対するおよび酸化防止剤としてのLaserpitiumsilerL.のエッセンシャルオイルの化粧的使用方法
EP2801347B1 (de) * 2013-05-10 2019-08-07 Rahn Ag Carboxylierte Stilbene zur Aktivierung von AMPK und Sirtuinen
FR3036617B1 (fr) 2015-05-27 2018-08-31 L'oreal Derives (1-phenyl-2-phenyl) ethylene polyhydroxyles a titre d'agent anti-age et photoprotecteur
CN108289809B (zh) 2015-06-05 2021-12-03 汤姆卡特国际有限公司 刺激透明质酸合成的方法
FR3036956B1 (fr) * 2015-06-05 2019-12-20 President And Fellows Of Harvard College Methode de stimulation de la synthese de l'acide hyaluronique
FR3049602B1 (fr) * 2016-03-31 2021-10-15 Oreal Derives polyphenols carboxyles et leur utilisation cosmetique
JP6364143B2 (ja) * 2016-07-28 2018-07-25 香港友池有限公司 Type17コラーゲン産生促進剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430062A (en) * 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
DE4305788C2 (de) * 1993-02-25 1997-06-12 Beiersdorf Ag Kosmetische und dermatologische Formulierungen zum Schutze der Haut gegen Oxidationsprozesse
EP0716589A4 (de) * 1993-07-23 1997-06-11 Morris Herstein Kosmetische, die hauterneuerung stimulierende zusammensetzung mit langzeit-irritationskontrolle
US5723291A (en) * 1993-09-01 1998-03-03 The Regents Of The University Of California Methods for screening compounds for estrogenic activity
CA2175581C (en) * 1993-11-12 1999-12-14 Donald Lynn Bissett Desquamation compositions containing salicylic acid and zwitterionic compounds
EP0704210B1 (de) * 1994-09-30 2002-12-04 L'oreal Verwendung von einem Agonisten eines mit einem Chloridkanal assozierten Rezeptors zur Behandlung von Hautfalten
JPH08175960A (ja) * 1994-12-27 1996-07-09 Kao Corp シワ予防用化粧料
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
JP3053368B2 (ja) * 1996-06-06 2000-06-19 ユシロ化学工業株式会社 化粧料及びその製造方法
FR2766176B1 (fr) * 1997-07-15 1999-10-29 Caudalie Compositions a base de derives de resveratrol
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.

Also Published As

Publication number Publication date
EP0953346A1 (de) 1999-11-03
DE69913023D1 (de) 2004-01-08
FR2777186B1 (fr) 2001-03-09
FR2777186A1 (fr) 1999-10-15
EP0953346B1 (de) 2003-11-26
JPH11322577A (ja) 1999-11-24
CA2266796A1 (fr) 1999-10-10
US6147121A (en) 2000-11-14
DE69913023T2 (de) 2004-08-12
ES2212487T3 (es) 2004-07-16

Similar Documents

Publication Publication Date Title
ATE254905T1 (de) Verwendung mindestens eines hydroxystilben in einer straffenden zusammensetzung
HUP0103236A2 (hu) Bőr- és szövetápoló és/vagy kezelő készítmény
DE69900081D1 (de) Haut- und/oder Haardepigmentierungsmittel
BR9806118A (pt) Processos para tratamento de pigmentação de pele
MY115628A (en) Cosmetic composition
BR9810084A (pt) Panos antimicrobianos
AU3162901A (en) Reducing damage to hair during oxidative processes
BR9702539A (pt) Composição cosmética e/ou dermatológica processo de tratamento cosmético processo não-terapêutico para despigmentar a pele do rosto e/ou do corpo humano utilização da composição e utilização de um polímero
GB2357969A (en) Improvements in or relating to the treatment of lesions
DE69916810D1 (de) Antimikrobieller hautlotion enthaltendes tissuepapier
TR200000695T2 (tr) Cildin durumunu iyileştirmek için bir yöntem.
DE59703511D1 (de) Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
BR9702541A (pt) Composição cosmética e/ou dermatológica utilização da composição e processo para tratamento não-terapêutico cosmético
AR006405A1 (es) Utilizacion de un extracto de al menos un iridacea en el tratamiento de las arrugas.
ID26791A (id) Formulasi untuk pencegahan atau perlakuan penyakit yang mempengaruhi mukosa atau kulit, atau untuk pencegahan kehamilan dan alat pemakai terhadap pengiriman formulasi topikal didalam rongga-rongga mukosal
FR2777183B1 (fr) Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
DE69923044D1 (de) Gewebebehandlungsmittel, Gewebe, Textildruckverfahren sowie Druck
ES2184971T3 (es) Utilizacion de polidimetilsiloxanos de grupos glucosidos como agentes hidratantes en una composicion cosmetica o dermatologica.
MX9700244A (es) Utilizacion de un poliholosido en una composicion limpiadora o desmaquillante, y composicion que lo incluye.
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
BR0115389A (pt) Composição cosmética, método cosmético e uso de composição tópica
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
DE69917756D1 (de) Methoden zur behandlung von neurombedingten schmerzen
AU5630399A (en) Use of at least a10-hydroxy-2- decenoic acid derivative in composition for promoting skin scaling
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0953346

Country of ref document: EP

REN Ceased due to non-payment of the annual fee